However, the downstream signaling pathways impacting on the development of HCC via SphK1 are organ specific providing further evidence that simply transferring known oncogenic molecular pathway targeting into HCC is not always valid. The gene discussed is SPHK1; the disease is hepatocellular carcinoma.